Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FSH Muscular Dystrophy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07136844
What this trial is testing

Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology

Who this might be right for
Neuromuscular DiseasesObesity (Disorder)Myotonic Dystrophy 1+9 more
Centre Hospitalier Universitaire de Liege 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT05548556
What this trial is testing

Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy

Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
Hoffmann-La Roche 51
Not applicableLooking for participantsNCT06600308
What this trial is testing

Walking ANalysis Interest in Persons wiTh facioscapulohumEral Muscular Dystrophies

Who this might be right for
Facioscapulohumeral Dystrophy
Centre Hospitalier Universitaire Dijon 60
Not applicableLooking for participantsNCT07478172
What this trial is testing

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease

Who this might be right for
Neuromuscular Diseases (NMD)Amyotrophic Lateral SclerosisMyasthenia Gravis+15 more
University of Missouri-Columbia 50
Testing effectiveness (Phase 2)Ended earlyNCT02927080
What this trial is testing

Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 95
Not applicableStudy completedNCT02413190
What this trial is testing

Bone Health in Facioscapulohumeral Muscular Dystrophy

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
Hugo W. Moser Research Institute at Kennedy Krieger, Inc. 94
Not applicableLooking for participantsNCT00082108
What this trial is testing

Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry

Who this might be right for
Myotonic DystrophyFacioscapulohumeral Muscular DystrophyMuscular Dystrophy+6 more
University of Rochester 3,000
Testing effectiveness (Phase 2)Study completedNCT02579239
What this trial is testing

Evaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
Limb-Girdle Muscular DystrophiesFacioscapulohumeral Muscular Dystrophy
aTyr Pharma, Inc. 18
Not applicableStudy completedNCT04694456
What this trial is testing

Pro-inflammatory Cytokines in Facioscapulohumeral Muscular Dystrophy (CYTOKINE-FSH)

Who this might be right for
Muscular Dystrophies
Centre Hospitalier Universitaire de Nice 30
Not applicableStudy completedNCT00004685
What this trial is testing

Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular Dystrophy

Who this might be right for
Muscular Dystrophy, Facioscapulohumeral
Ohio State University 90
Not applicableStudy completedNCT01618331
What this trial is testing

Protein Supplementation and Exercise in Patients With FSH Muscular Dystrophy- a Randomized Placebo Controlled Study

Who this might be right for
Facioscapulohumeral Muscle Dystrophy
Grete Andersen, MD 42
Testing effectiveness (Phase 2)Study completedNCT02239224
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Participants With Muscular Dystrophy

Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
aTyr Pharma, Inc. 20
Not applicableLooking for participantsNCT06708468
What this trial is testing

Personalized Training for People With Rare Neuromuscular Disorders

Who this might be right for
Neuromuscular Diseases (NMD)Charcot Marie Tooth Disease (CMT)Facioscapulohumeral Muscular Dystrophy+1 more
Oslo University Hospital 120
Not applicableEnded earlyNCT06096441
What this trial is testing

FSHD Molecular Characterization

Who this might be right for
Facio-Scapulo-Humeral Dystrophy
Nationwide Children's Hospital 1
Not applicableActive Not RecruitingNCT05453461
What this trial is testing

ADVANCED FSHD-COM: New Clinical Outcome Measures to Evaluate Non-ambulant FSHD Patients, a Pilot Study

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
Centre Hospitalier Universitaire de Nice 30
Not applicableNot Yet RecruitingNCT06917430
What this trial is testing

Muscle MRI Outlining of Neuromuscular Diseases Using Artificial Intelligence

Who this might be right for
Becker Muscular DystrophyFSHD - Facioscapulohumeral Muscular DystrophyHypokalemic Periodic Paralysis
Rigshospitalet, Denmark 120
Not applicableStudy completedNCT06363357
What this trial is testing

The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients With Neuromuscular Disorder

Who this might be right for
Muscular Dystrophy, DuchenneOrthotic DevicesUpper Extremity+6 more
Seoul National University Hospital 8
Not applicableStudy completedNCT02159612
What this trial is testing

1 Year MRI Followup in Facioscapulohumeral Muscular Dystrophy

Who this might be right for
FSHD - Facioscapulohumeral Muscular Dystrophy
Grete Andersen, MD 45
Not applicableEnrolling By InvitationNCT07072676
What this trial is testing

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

Who this might be right for
Inclusion Body MyositisMyotonic Dystrophy 1Myotonic Dystrophy 2+10 more
LMU Klinikum 30
Testing effectiveness (Phase 2)Ended earlyNCT03943290
What this trial is testing

Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX)

Who this might be right for
Facioscapulohumeral Muscular DystrophyCharcot-Marie-Tooth Disease
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 62
Next Page